Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas
AuthorsHanna Gött; Jonas Tellermann; Hannes Becker; Christina Fodi; Peter Paßlack; Elgin Hoffmann; Maria Elisa Di Francesco; Daniel J. Merk; Jürgen Honegger; Ghazaleh Tabatabai; Marcos Tatagiba; Felix Behling; Jens Schittenhelm
Affiliations1. Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 2. Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 3. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 4. Cluster of Excellence (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, Eberhard-Karls University Tübingen, Tübingen, Germany; 5. Department of Anesthesiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 6. Department of Radiation Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 7. Department of Ophthalmology, Inselspital Bern, University of Bern, Bern, Switzerland; 8. German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany; 9. Department of Neurosurgery, Faculty of Medicine, Augsburg University, Augsburg, Germany; 10. Translational Oncological Neurosurgery, Faculty of Medicine, University Augsburg, Augsburg, Germany; 11. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany
A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases
AuthorsLeonie Sowoidnich; Aaron L. Norman; Florian Gerstner; Josiane K. Siemund; Jannik M. Buettner; John G. Pagiazitis; Vanessa Dreilich; Konstantin Pilz; Dajun Tian; Charlotte J. Sumner; Angela Paradis; George Z. Mentis; Christian M. Simon
Affiliations1. Carl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany; 2. Center for Motor Neuron Biology and Disease, Columbia University, New York, USA; 3. Depts. of Pathology and Cell Biology and Neurology, Columbia University, New York, USA; 4. Biogen, Cambridge, USA; 5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 6. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA; 7. Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation
AuthorsLazaros Lazaridis; Xiaomei Zhou; Raphael Bodensohn; Malte Mohme; Julia Onken; Regina von Manitius; Naomi Houedjissin; Tobias Blau; Ilinca Popp; Sarina Agkatsev; Sabine Seidel; Christina Schaub; Maximilian Scheer; Andre Sagerer; Volker Neuschmelting; Davide Tosin; Viktoria Ruf; Michael C. Burger; Christoph Oster; Teresa Schmidt; Benjamin Thiele; Jürgen Hench; Stephan Frank; Martin Stuschke; Laurèl Rauschenbach; Stephan Tippelt; Beate Timmermann; Kathy Keyvani; Clemens Seidel; Andrea Tannapfel; Dorothea Miller; Niklas Thon; Joachim P. Steinbach; Elke Pfaff; Georg Karpel-Massler; Jörg Felsberg; Guido Reifenberger; Marcos Tatagiba; Ghazaleh Tabatabai; Jens Schittenhelm; Christian Thomas; Martin Hasselblatt; Corinna Seliger; Christoph Kleinschnitz; Ulrich Sure; David Capper; Michael Platten; Felix Behling; Michael Müther; Sied Kebir
Affiliations1. Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 2. Division of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 3. Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany; 4. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany; 6. Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; 7. Department of Neurosurgery, Medical Faculty, Center of Neuro-Oncology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; 8. Institute of Neuropathology, University Medicine Essen, Essen, Germany; 9. Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 10. Department of Neurooncology, Centers for Neurology and Integrated Oncology (CIO), University Hospital Bonn, Bonn, Germany; 11. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; 12. Department of Neurosurgery, Universität Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 13. Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 14. Department of Neurological Surgery, Ulm University Medical Center, Ulm, Germany; 15. Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany; 16. Goethe University, Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt Am Main, Germany; 17. German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, a Partnership Between DKFZ and University Hospital Essen, Germany, DKFZ-Division Translational Neuro-Oncology at the West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 18. Medical Oncology, University Hospital Basel, Basel, Switzerland; 19. Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland; 20. Institute for Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland; 21. Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 22. Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 23. Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital of Essen, Essen, Germany; 24. Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; 25. German Cancer Consortium (DKTK), Essen, Germany; 26. Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany; 27. Institute of Pathology, Ruhr University Bochum, Bochum, Germany; 28. Department of Neurosurgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 29. Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany; 30. Institute of Neuropathology, Medical Faculty, Heinrich-Heine-University Düsseldorf, and University Hospital Düsseldorf, Düsseldorf, Germany; 31. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 32. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard-Karls-University Tübingen, Tübingen, Germany; 33. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 34. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 35. German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 36. Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany; 37. Department of Neurosurgery, Faculty of Medicine, University of Augsburg, Augsburg, Germany; 38. Department of Neurosurgery, University Hospital Münster, Münster, Germany
Overactivation of SHH signaling induces a cascade of dedifferentiation and oncogenesis in a new mouse model for choroid plexus carcinoma
AuthorsLevke-Sophie Peter; Lea Altendorf; Karoline Hack; Vanessa Thaden; Carolin Göbel; Beatrix Mahnke; Christian Krebs; Saskia-L. Jauch-Speer; Uwe R. Kordes; Denise Obrecht-Sturm; Christian Thomas; Ulrich Schüller; Melanie Schoof
Affiliations1. Research Institute Children’s Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3. III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4. Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Single Cell Core Facility, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 7. Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 8. Mildred Scheel Cancer Career Centre HaTriCS4, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
Reduced microvascular coverage links a hypoxia-associated niche to microglial autophagic dysfunction in Parkinson’s disease
AuthorsHualin Wang; Zhuang Zhu; Zefu Yin; Yao Geng; Yihang Xu; Yi Fan; Kezhong Zhang
Affiliations1. Department of Neurology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; 2. The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China; 3. Rehabilitation Medicine Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, People’s Republic of China; 4. Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
Immune niches in brain tumors: glial–immune cell interactions and spatial microdomains
AuthorsQian Guo; Sihang Shen; Zhouyuan Zhang; Meirong Shan; Bochen Pan; Xiao Yu; Yi Chen
Affiliations1. Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. School of Acupuncture-Moxibustion and Tuina & School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China; 3. School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 4. Department of Geriatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 5. Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China; 6. Department of Otolaryngology–Head and Neck Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Cancer Research Institute, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China
Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies
AuthorsFlorian Almela; Maxime Belondrade; Raphaelle Caillierez; Sarah Leclercq; Thomas Bouillet; Séverine Bégard; Marie Oosterlynck; Sabiha Eddarkaoui; Susana Boluda; Luc Buée; Simon Nicot; Morvane Colin; Daisy Bougard
Affiliations1. Laboratoire TransDiag, Etablissement Français du Sang, Montpellier, France; 2. Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM, EFS, Montpellier, France; 3. UMR-S1172 Lille Neuroscience & Cognition (LilNCog), University of Lille, Inserm, CHU Lille, Lille, France; 4. Department of Neuropathology, DMU Neuroscience, AP-HP, Paris Brain Institute-ICM, Inserm, CNRS, Hôpital de la Pitié Salpêtrière, Sorbonne University, Paris, France
Overactive EAAT1 Cl − channels impair GABAergic tonic inhibition in SLC1A3 -associated episodic ataxia
AuthorsYulia Kostritskaia; Daniela Bulla-Miely; Miriam Engels; Jan Meyer; Juliane L. Berns; Sabrina Behuet; Sebastian Bludau; Christine R. Rose; Albert Becker; Thomas Gensch; Ulrike B. S. Hedrich; Christoph Fahlke; Peter Kovermann
Affiliations1. Institute of Biological Information Processing, Molekular- und Zellphysiologie (IBI-1), Forschungszentrum Jülich, Jülich, Germany; 2. MSH Medical School Hamburg, Hamburg, Germany; 3. Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; 4. Institute of Neurobiology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; 5. Institute for Cellular Neurosciences II, Universitätsklinikum Bonn, Bonn, Germany; 6. Institute of Neuroscience and Medicine, Strukturelle und funktionelle Organisation des Gehirns (INM-1), Forschungszentrum Jülich GmbH, Jülich, Germany
Galectin-3 is elevated in Müller glia in human glaucomatous eyes and ocular hypertensive rat eyes and associated with phagocytosing states
AuthorsAnne Rombaut; Luozixian Wang; Emma Lardner; Raymond CB Wong; Charlotte Taul; Miriam Kolko; Gustav Stålhammar; Rune Brautaset; Filippo Locri; Pete A. Williams; James R. Tribble
Affiliations1. Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden; 2. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia; 3. Department of Surgery (Ophthalmology), The University of Melbourne, Melbourne, Australia; 4. Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; 5. Department of Ophthalmology, Copenhagen University Hospital, Glostrup, Denmark; 6. Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark; 7. Wolfson Sensory, Pain and Regeneration Centre (SPaRC), School of Neuroscience, King’s College London, London, UK
Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma
AuthorsLuisa Voßbeck; Felix Ehret; Eilis Perez; Helena Radbruch; Elisabeth G. Hain; Simone Schmid; Julia Onken; Merten Bohn; Nabiha Salman; Leonille Schweizer; David Capper; Moritz Armbrust; David Kaul
Affiliations1. Department of Radiation Oncology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 2. German Cancer Consortium (DKTK), Partner Site Berlin, A Partnership Between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany; 3. Department of Neuropathology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 4. Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 5. Institute of Neurology (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany; 6. Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany; 7. German Cancer Consortium (DKTK), Partner Site Frankfurt, German Cancer Research Center (DKFZ), Heidelberg, Germany; 8. Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany; 9. Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt am Main, Germany
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
